Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity

Van Meir, 2010, Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma, CA. Cancer. J. Clin., 60, 166, 10.3322/caac.20069 Hernández-Pedro, 2013, Application of nanoparticles on diagnosis and therapy in gliomas, Biomed. Res. Int., 2013, 351031, 10.1155/2013/351031 Gao, 2013, Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization, Sci. Report., 3, 2534, 10.1038/srep02534 Zhao, 2011, The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats, J. Drug Target., 19, 382, 10.3109/1061186X.2010.504267 Farkhani, 2014, Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules, Peptides, 57, 78, 10.1016/j.peptides.2014.04.015 Hervé, 2008, CNS delivery via adsorptive transcytosis, AAPS J., 10, 455, 10.1208/s12248-008-9055-2 Qin, 2011, Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery, Int. J. Pharm., 419, 85, 10.1016/j.ijpharm.2011.07.021 Zong, 2014, Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT, J. Pharm. Sci., 103, 3891, 10.1002/jps.24186 Zong, 2014, Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals, Mol. Pharm., 11, 2346, 10.1021/mp500057n Sharma, 2014, Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier, Pharm. Res., 31, 1194, 10.1007/s11095-013-1242-x Tanaka, 2010, Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing, Int. J. Pharm., 398, 219, 10.1016/j.ijpharm.2010.07.038 Sun, 2014, Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers, Mol. Pharm., 11, 1583, 10.1021/mp400747k Zhang, 2015, High tumor penetration of paclitaxel loaded pH sensitive cleavable liposomes by depletion of tumor collagen I in breast cancer, ACS Appl. Mater. Interfaces, 7, 9691, 10.1021/acsami.5b01473 Zhao, 2012, The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel, Biomaterials, 33, 2508, 10.1016/j.biomaterials.2011.11.078 Paliwal, 2015, A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery, Drug. Deliv., 22, 231, 10.3109/10717544.2014.882469 Chang, 2015, RGD-modified pH-sensitive liposomes for docetaxel tumor targeting, Colloids Surf. B: Biointerfaces, 129, 175, 10.1016/j.colsurfb.2015.03.046 Tacar, 2013, Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems, J. Pharm. Pharmacol., 65, 157, 10.1111/j.2042-7158.2012.01567.x Luo, 2013, Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel, Biomaterials, 34, 1102, 10.1016/j.biomaterials.2012.10.029 Timofeev, 1994, Liposomal diamidine (imidocarb): preparation and animal studies, J. Microencapsul., 11, 627, 10.3109/02652049409051112 Ishida, 2001, Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells, Biochim. Biophys. Acta, 1515, 144, 10.1016/S0005-2736(01)00409-6 Yu, 2013, The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation, Int. J. Nanomedicine, 8, 2473 Wang, 2015, The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo, Int. J. Nanomedicine, 10, 2229 Wu, 2014, Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect, Int. J. Nanomedicine, 9, 5261 Sharma, 2014, Influence of short-chain cell-penetrating peptides on transport of doxorubicin encapsulating receptor-targeted liposomes across brain endothelial barrier, Pharm. Res., 31, 1194, 10.1007/s11095-013-1242-x García-Martín, 2001, Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites, Cancer Res., 61, 6524 Bhujbal, 2014, Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors, Adv. Drug Deliv. Rev., 67-68, 142, 10.1016/j.addr.2014.01.010 Bellavance, 2010, Uptake and intracellular release kinetics of liposome formulations in glioma cells, Int. J. Pharm., 395, 251, 10.1016/j.ijpharm.2010.05.017 Pacheco-Torres, 2015, Image guided drug release from pH-sensitive ion channel-functionalized stealth liposomes into an in vivo glioblastoma model, Nanomedicine, 11, 1345, 10.1016/j.nano.2015.03.014 Simões, 2001, On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes, Biochim. Biophys. Acta, 1515, 23, 10.1016/S0005-2736(01)00389-3 Slepushkin, 1997, Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo, J. Biolumin. Chemilumin., 272, 2382 Drummond, 2000, Current status of pH-sensitive liposomes in drug delivery, Prog. Lipid Res., 39, 409, 10.1016/S0163-7827(00)00011-4 Ferreira Ddos, 2013, pH-sensitive liposomes for drug delivery in cancer treatment, Ther. Deliv., 4, 1099, 10.4155/tde.13.80 El Hallani, 2010, A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry, Brain, 133, 973, 10.1093/brain/awq044 Buie, 2008, Bevacizumab: a treatment option for recurrent glioblastoma multiforme, Ann. Pharmacother., 42, 1486, 10.1345/aph.1L030 Wang, 2002, Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide, Biochem. J., 367, 729, 10.1042/bj20020752 Pastorino, 2003, Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy, Cancer Res., 63, 7400 Zhang, 2002, Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis, Cancer Res., 62, 2034 Lila, 2013, The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage, J. Control. Release, 172, 38, 10.1016/j.jconrel.2013.07.026 Ishida, 2003, Accelerated clearance of PEGylated liposomes in rats after repeated injections, J. Control. Release, 88, 35, 10.1016/S0168-3659(02)00462-5 Ishida, 2006, Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes, J. Control. Release, 112, 15, 10.1016/j.jconrel.2006.01.005 Ishida, 2005, Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes, J. Control. Release, 105, 305, 10.1016/j.jconrel.2005.04.003